Ascendis Pharma A/S (ASND)
133.62
+0.49
(+0.37%)
USD |
NASDAQ |
May 10, 16:00
133.62
0.00 (0.00%)
After-Hours: 18:01
Ascendis Pharma Gross Profit Margin (Quarterly): 92.11% for March 31, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 92.11% |
| December 31, 2023 | 85.87% |
| September 30, 2023 | 84.62% |
| June 30, 2023 | 72.72% |
| March 31, 2023 | 86.24% |
| Date | Value |
|---|---|
| December 31, 2022 | 77.67% |
| September 30, 2022 | 88.93% |
| June 30, 2022 | 82.37% |
| March 31, 2022 | 37.81% |
| December 31, 2021 | 28.06% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
28.06%
Minimum
Dec 2021
92.11%
Maximum
Mar 2024
73.64%
Average
83.49%
Median
Gross Profit Margin (Quarterly) Benchmarks
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | -58.56% |
| Return on Invested Capital | -98.10% |
| Profit Margin (Quarterly) | -136.6% |
| Operating Margin (Quarterly) | -51.25% |
| Return on Net Operating Assets | -124.8% |